C WorldWide Group Holding A S cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 25.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 71,382 shares of the company’s stock after selling 23,931 shares during the period. C WorldWide Group Holding A S’s holdings in Cardinal Health were worth $5,562,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the stock. Gulf International Bank UK Ltd boosted its stake in Cardinal Health by 1.3% in the first quarter. Gulf International Bank UK Ltd now owns 98,741 shares of the company’s stock valued at $8,052,000 after buying an additional 1,300 shares during the period. Quadrant Capital Group LLC boosted its stake in Cardinal Health by 6.3% in the first quarter. Quadrant Capital Group LLC now owns 1,972 shares of the company’s stock valued at $156,000 after buying an additional 116 shares during the period. National Pension Service boosted its stake in Cardinal Health by 1.8% in the first quarter. National Pension Service now owns 260,907 shares of the company’s stock valued at $21,308,000 after buying an additional 4,712 shares during the period. Legacy Private Trust Co. boosted its stake in Cardinal Health by 20.2% in the first quarter. Legacy Private Trust Co. now owns 4,530 shares of the company’s stock valued at $369,000 after buying an additional 760 shares during the period. Finally, Bank of Montreal Can boosted its stake in Cardinal Health by 6.2% in the first quarter. Bank of Montreal Can now owns 609,732 shares of the company’s stock valued at $49,725,000 after buying an additional 35,436 shares during the period. Institutional investors own 87.09% of the company’s stock.

Cardinal Health, Inc. (NYSE CAH) opened at 67.31 on Friday. The stock has a market cap of $21.27 billion, a PE ratio of 16.70 and a beta of 0.80. The firm has a 50-day moving average price of $76.01 and a 200-day moving average price of $76.91. Cardinal Health, Inc. has a 12-month low of $62.70 and a 12-month high of $84.88.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.07. The business had revenue of $32.97 billion for the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.14 EPS. Analysts forecast that Cardinal Health, Inc. will post $4.97 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be issued a dividend of $0.4624 per share. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.75%. The ex-dividend date of this dividend is Friday, September 29th. Cardinal Health’s dividend payout ratio is 45.79%.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/11/cardinal-health-inc-cah-position-reduced-by-c-worldwide-group-holding-a-s.html.

CAH has been the subject of several recent analyst reports. William Blair cut Cardinal Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, April 19th. Leerink Swann set a $72.00 price target on Cardinal Health and gave the company a “hold” rating in a report on Friday, April 21st. Barclays PLC reiterated an “overweight” rating and set a $82.00 target price (down previously from $88.00) on shares of Cardinal Health in a report on Saturday, April 22nd. Cowen and Company decreased their target price on Cardinal Health from $89.00 to $82.00 and set a “market perform” rating for the company in a report on Tuesday, April 25th. Finally, Zacks Investment Research cut Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday, April 28th. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $80.46.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.